Laurence Cahen‐Doidy

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15

Jacqueline Lehmann‐Che, Anne‐Sophie Hamy, Raphaël Porcher et al. · Breast Cancer Research · 2013 · 100 citations · Full text

Medicine, Molecular Biology, Oncology +17

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches

F. Amira-Bouhidel, E Turpin, Martine Antoine et al. · British Journal of Cancer · 2011 · 60 citations · Full text

Medicine, Oncology, Pathology +17

Breast Intracystic Papillary Carcinoma: An Update

Julien Caldéraro, Marc Espié, J. Duclos et al. · The Breast Journal · 2009 · 45 citations

Medicine, Oncology, Pathology +17

10-Year follow-up of 621 patients treated using high-dose rate brachytherapy as ambulatory boost technique in conservative breast cancer treatment

L. Quéro, S. Guillerm, Naila Taright et al. · Radiotherapy and Oncology · 2016 · 15 citations

Medicine, Oncology, Radiation Oncology +11

Impact of radical surgery on outcome in locally advanced breast cancer patients without metastasis at the time of diagnosis.

M. Nikpayam, Catherine Uzan, Sofía Rivera et al. · PubMed · 2015 · 14 citations

Medicine, Oncology, Surgery +17